TY - JOUR
T1 - The relative burden of dry eye in patients' lives
T2 - Comparisons to a U.S. normative sample
AU - Mertzanis, Polyxane
AU - Abetz, Linda
AU - Rajagopalan, Krithika
AU - Espindle, Derek
AU - Chalmers, Robin
AU - Snyder, Christopher
AU - Caffery, Barbara
AU - Edrington, Timothy
AU - Simpson, Trefford
AU - Nelson, J. Daniel
AU - Begley, Carolyn
PY - 2005/1
Y1 - 2005/1
N2 - PURPOSE. To assess the relative burden of dry eye in daily life by comparing Short Form-36 (SF-36) responses from individuals with and without dry eye against U.S. norms. METHODS. Assessment of 210 people, 130 with non-Sjögren's keratoconjunctivitis sicca (non-SS KCS), 32 with Sjögren's Syndrome (SS), and 48 control subjects. The study population data and published normative SF-36 data were compared. Dry eye severity was assessed by recruited severity (control, non-SS KCS, SS), patient self-report (none, very mild/mild, moderate, severe/extremely severe), and clinician-report (none, mild, moderate, severe). Age- and gender-matched norms were compared with all defined severity groups. RESULTS. Compared with the norms, control subjects scored higher on all SF-36 scales. Effect size (ES) ranged from 0.15 to 0.52. Non-SS KCS patients had lower Role-Physical (ES = -0.07), Bodily Pain (ES = -0.08), and Vitality (ES = -0.11) scores, indicating more dry eye impact on those areas versus the norm. All SF-36 scale scores except Mental Health (ES = 0.12) were lower in the SS group than the adjusted norm (ES range: -0.16 to -0.99). Regardless of severity classification, mild patients consistently had lower Role-Physical and Bodily Pain scores than the norm, suggesting impact on daily roles (ES < 0.2). Patients with moderately severe disease also experienced less vitality and poorer general health. The group with severe disease scored lower than the norm across all domains (ES range: -0.14 to -0.91) except Role-Emotional (ES = 0.13) and Mental Health (ES = 0.23). CONCLUSIONS. These results indicate dry eye's negative impact on everyday life, particularly in daily activities. Further research using disease-specific measures to examine dry eye's impact is underway.
AB - PURPOSE. To assess the relative burden of dry eye in daily life by comparing Short Form-36 (SF-36) responses from individuals with and without dry eye against U.S. norms. METHODS. Assessment of 210 people, 130 with non-Sjögren's keratoconjunctivitis sicca (non-SS KCS), 32 with Sjögren's Syndrome (SS), and 48 control subjects. The study population data and published normative SF-36 data were compared. Dry eye severity was assessed by recruited severity (control, non-SS KCS, SS), patient self-report (none, very mild/mild, moderate, severe/extremely severe), and clinician-report (none, mild, moderate, severe). Age- and gender-matched norms were compared with all defined severity groups. RESULTS. Compared with the norms, control subjects scored higher on all SF-36 scales. Effect size (ES) ranged from 0.15 to 0.52. Non-SS KCS patients had lower Role-Physical (ES = -0.07), Bodily Pain (ES = -0.08), and Vitality (ES = -0.11) scores, indicating more dry eye impact on those areas versus the norm. All SF-36 scale scores except Mental Health (ES = 0.12) were lower in the SS group than the adjusted norm (ES range: -0.16 to -0.99). Regardless of severity classification, mild patients consistently had lower Role-Physical and Bodily Pain scores than the norm, suggesting impact on daily roles (ES < 0.2). Patients with moderately severe disease also experienced less vitality and poorer general health. The group with severe disease scored lower than the norm across all domains (ES range: -0.14 to -0.91) except Role-Emotional (ES = 0.13) and Mental Health (ES = 0.23). CONCLUSIONS. These results indicate dry eye's negative impact on everyday life, particularly in daily activities. Further research using disease-specific measures to examine dry eye's impact is underway.
UR - http://www.scopus.com/inward/record.url?scp=19944396466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=19944396466&partnerID=8YFLogxK
U2 - 10.1167/iovs.03-0915
DO - 10.1167/iovs.03-0915
M3 - Article
C2 - 15623753
AN - SCOPUS:19944396466
SN - 0146-0404
VL - 46
SP - 46
EP - 50
JO - Investigative Ophthalmology and Visual Science
JF - Investigative Ophthalmology and Visual Science
IS - 1
ER -